Recent News

Black, white men view impacts of prostate cancer treatment differently, study finds

Black, white men view impacts of prostate cancer treatment differently, study finds

UNC Lineberger researchers led by Ronald C. Chen, MD, MPH, surveyed 1,171 men diagnosed with prostate cancer in North Carolina, finding that while both white and black men were concerned about curing their cancer and the quality-of-life impacts of treatment, more black men considered other social and personal factors -- such as recovery time and cost -- to be very important in their treatment decision-making.

Black, white men view impacts of prostate cancer treatment differently, study finds - Read More…

Cancer patients who systematically reported their symptoms lived longer

Cancer patients who systematically reported their symptoms lived longer

A study presented by Ethan Basch, MD, MSc, at the American Society of Clinical Oncology is the first to find a survival benefit for patient reported outcomes.

Cancer patients who systematically reported their symptoms lived longer - Read More…

With ‘new life’ after transplant, cancer survivor renews marriage vows

With ‘new life’ after transplant, cancer survivor renews marriage vows

Recognizing that her husband now had a chance for a new, healthier life thanks to a stem cell transplant, Jackie Hannah secretly arranged for a ceremony for her husband David and her to renew their marriage vows. While he was in the Bone Marrow Transplant Unit in March, just after the transplant, and still dressed in his pajamas, David married Jackie again with hospital staff in attendance.

With ‘new life’ after transplant, cancer survivor renews marriage vows - Read More…

Payments linked to higher odds of doctors prescribing certain cancer drugs

Payments linked to higher odds of doctors prescribing certain cancer drugs

In preliminary findings presented at the American Society of Clinical Oncology Annual Meeting 2017, researchers show that when physicians had to choose between multiple, on-patent drugs for metastatic kidney cancer and chronic myeloid leukemia, they were more likely to prescribe drugs from companies they had received general payments from.

Payments linked to higher odds of doctors prescribing certain cancer drugs - Read More…